Framework for evaluating disease severity measures in older adults with comorbidity

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 3, 2007, Pages 286-295

  Boyd, Cynthia M ^a,b   Weiss, Carlos O ^a,b   Halter, Jeff ^c   Han, K Carol ^b   Ershler, William B ^e   Fried, Linda P ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Institute for Advanced Studies in Aging and Geriatric Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CLINICAL DECISION MAKING; COMORBIDITY; COST; DISEASE SEVERITY; EVALUATION; HUMAN; PRIORITY JOURNAL; RELIABILITY; SYSTEMATIC REVIEW; VALIDITY; CHRONIC DISEASE; CLASSIFICATION; COST BENEFIT ANALYSIS; DAILY LIFE ACTIVITY; HEALTH STATUS; HOSPITALIZATION; OUTCOME ASSESSMENT; REPRODUCIBILITY; REVIEW;

ACTIVITIES OF DAILY LIVING; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; HEALTH STATUS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 34248522807     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.3.286     Document Type: Article

References (91)

1. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
2. Yokota C, Minematsu K, Hasegawa Y, Yamaguchi T. Long-term prognosis, by stroke subtypes, after a first-ever stroke: a hospital-based study over a 20-year period. Cerebrovasc Dis. 2004;18:111-116.
3. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661-674.
4. Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51.
5. Verbrugge LM, Lepkowski JM, Imanaka Y. Comorbidity and its impact on disability. Milbank Q. 1989;67:450-484.
6. Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of comorbidity with disability in older women: the Women's Health and Aging Study. J Clin Epidemiol. 1999;52:27-37.
7. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520.
8. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med. 2004;164:1957-1959.
9. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716-724.
10. Kravitz RL, Duan N, Braslow J. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q. 2004;82:661-687.
11. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870-2874.
12. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
13. Wallace RB. Bone health in nursing home residents. JAMA. 2000;284:1018-1019.
14. Zimmerman SI, Girman CJ, Buie VC, et al. The prevalence of osteoporosis in nursing home residents. Osteoporos Int. 1999;9: 151-157.
15. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59A:255-263.
16. Pope AM, Taylor AR. Disability in America. Washington, D.C.: National Academy Press; 1991.
17. Dawson DA, Adams PF. Current Esimates from the National Health Interview Survey, United States, 1986. National Center for Health Statistics. Vital Health Stat Series No. 10(164). 1987.
18. Freedman VA, Martin LG. Contribution of chronic conditions to aggregate changes in old-age functioning. Am J Public Health. 2000;90:1755-1760.
19. Disparities in screening for and awareness of high blood cholesterol-United States, 1999-2002. MMWR Morb Mortal Wkly Rep. 2005;54:117-119.
20. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
21. Wahl PW, Savage PJ, Psaty BM, Orchard TJ, Robbins JA, Tracy RP. Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet. 1998;352:1012-1015.
22. Rodriguez BL, Curb JD, Burchfiel CM, et al. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Diabetes Care. 1996;19:587-590.
23. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110:738-743.
24. Anderson G, Horvath J. Chronic Conditions: Making the Case for Ongoing Care. Partnership for Solutions; 2002. Available at: http://www. partnershipforsolutions.org/DMS/files/chronicbook2002.pdf. Last accessed December 21, 2006.
25. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care. 2002;47:1184-1199.
26. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104: 2263-2268.
27. Braman SS. Asthma in the elderly. Clin Geriatr Med. 2003;19:57-75.
28. Lash TL, Mor V, Wieland D, Ferrucci L, Satariano W, Silliman RA. Methodology, design and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci. 2007;62A: 281-285.
29. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457-464.
30. Dagenais GR, Armstrong PW, Theroux P, Naylor CD. Revisiting the Canadian Cardiovascular Society grading of stable angina pectoris after a quarter of a century of use. Can J Cardiol. 2002;18:941-944.
31. Braunwald E. Unstable angina. A classification. Circulation. 1989;80:410-414.
32. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64:1227-1234.
33. Consensus Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. Ninth Ed. Boston: Little, Brown & Co.; 1994.
34. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840.
35. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494-502.
36. LaValley MP, McAlindon TE, Chaisson CE, Levy D, Felson DT. The validity of different definitions of radiographic worsening for longitudinal studies of knee osteoarthritis. J Clin Epidemiol. 2001;54:30-39.
37. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop. 1989:13-14.
38. Ahlback S. Osteoarthrosis of the knee: a radiographic investigation. Acta Radiologics Suppl. 1968;277:7-72.
39. Lequesne MG, Maheu E. Clinical and radiological evaluation of hip, knee and hand osteoarthritis. Aging Clin Exp Res. 2003;15: 380-390.
40. Pelerfy CG, Gold G, Eckstein F, Cicuttini F, Dardzinski B, Stevens R. MRI protocols for whole-organ assessment of the knee in osteoarthritis. Osteoarthritis Cartilage. 2006;14(Suppl A):A95-A111.
41. Peterfy CG, Guermazi A, Zaim S, et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis Cartilage. 2004;12:177-190.
42. Riegel B, Moser DK, Glaser D, et al. The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nurs Res. 2002;51(4):209-218.
43. Grigioni F, Carigi S, Grandi S, et al. Distance between patients' subjective perceptions and objectively evaluated disease severity in chronic heart failure. Psychother Psychosom. 2003;72:166-170.
44. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage. 2003;25:420-429.
45. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-2667.
46. Zugck C, Kruger C, Kell R, el al. Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model. Eur J Heart Fail. 2001;3:577-585.
47. National Institutes of Health, National Heart, Lung, and Blood Institute. Third Report of the Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Full Report. Vol. 2004. Available at: http://www.nhlbi.nih. gov/guidelines/cholesterol/atp3full. pdf. Last accessed December 21, 2006.
48. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
49. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1187.
50. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-S266.
51. National Institutes of Health, National Heart, Lung, and Blood Institute. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). Vol. 2005. Available at: http://www.nhlbi.nih.gov/ guidelines/hypertension/jnc7full.pdf. Last accessed December 21, 2006.
52. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
53. Apelqvist J, Van Houtem WH, Nabuurs-Fransen MH, Shaper NC. International Consensus on the Diabetic Foot. The International Working Group on the Diabetic Foot. Amsterdam, The Netherlands: Wiley & Sons; 1999.
54. Recommendations for clinical trial evaluation of acute stroke therapies. Stroke. 2001;32:1598-1606.
55. Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke. 2002;33:1261-1266.
56. Miller PD, Barlas S, Brenneman SK, et al. An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med. 2004;164:1113-1120.
57. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45:1101-1109.
58. Mao HF, Hsueh IP, Tang PF, Sheu CF, Hsieh CL. Analysis and comparison of the psychometric properties of three balance measures for stroke patients. Stroke. 2002;33:1022-1027.
59. Duncan PW, Bode RK, Min Lai S, Perera S. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003;84:950-963.
60. Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke. 1999;30:2131-2140.
61. Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. Stroke. 2000;31:1429-1438.
62. Lyden P, Lu M, Jackson C, et al. Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke. 1999;30:2347-2354.
63. Johnston KC, Wagner DP, Haley EC Jr, Connors AF Jr. Combined clinical and imaging information as an early stroke outcome measure. Stroke. 2002;33:466-472.
64. Roberts L, Counsell C. Assessment of clinical outcomes in acute stroke trials. Stroke. 1998;29:986-991.
65. Muir KW, Grosset DG, Lees KR. Interconversion of stroke scales. Implications for therapeutic trials. Stroke. 1994;25:1366-1370.
66. van Straten A, de Haan RJ, Limburg M, van den Bos GA. Clinical meaning of the Stroke-Adapted Sickness Impact Profile-30 and the Sickness Impact Profile-136. Stroke. 2000;31:2610-2615.
67. Bushnell CD, Johnston DC, Goldstein LB. Retrospective assessment of initial stroke severity: comparison of the NIH Stroke Scale and the Canadian Neurological Scale. Stroke. 2001;32:656-660.
68. Nakajima M, Kimura K, Ogata T, Takada T, Uchino M, Minematsu K. Relationships between angiographic findings and National Institutes of Health stroke scale score in cases of hyperacute carotid ischemic stroke. AJNR Am J Neuroradiol. 2004;25:238-241.
69. Brott T, Adams HPJ, Olinger CP, et al. Measurements of acute cerebral infarction-a clinical examination scale. Stroke. 1989;20:864-870.
70. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian Neurological Scale: validation and reliability assessment. Neurology. 1989;39:638-643.
71. Kidd D, Stewart G, Baldry J, et al. The Functional Independence Measure: a comparative validity and reliability study. Disabil Rehabil. 1995;17:10-14.
72. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19:1497-1500.
73. Bergner M, Bobbin RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787-805.
74. Duncan PW, Wallace D, Studenski S, Lai SM, Johnson D. Conceptualization of a new stroke-specific outcome measure: the stroke impact scale. Top Stroke Rehabil. 2001;8:19-33.
75. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993;36:729-740.
76. Lydick E, Cook K, Turpin J, Melton M, Stine R, Byrnes C. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care. 1998;4:37-48.
77. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
78. Cadarette SM, Jaglal SB, Kreiger N, McIsaac WJ, Darlington GA, Tu JV. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ. 2000;162:1289-1294.
79. Weinstein L, Ullery B. Identification of at-risk women for osteoporosis screening. Am J Obstet Gynecol. 2000;183:547-549.
80. Michaelsson K, Bergstrom R, Mallmin H, Holmberg L, Wolk A, Ljunghall S. Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int. 1996;6:120-126.
81. Liard R, Leynaert B, Zureik M, Beguin FX, Neukirch F. Using Global Initiative for Asthma guidelines to assess asthma severity in populations. Eur Respir J. 2000;16:615-620.
82. Tinetti ME, Fried T. The end of the disease era. Am J Med. 2004;116:179-185.
83. Bellia V, Pistelli F, Giannini D, et al. Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients. Eur Respir J. 2003;21(40 Suppl):21S-27S.
84. Smith RF, Johnson G, Ziesche S, Bhat G, Blankenship K, Cohn JN. Functional capacity in heart failure. Comparison of methods for assessment and their relation to other indexes of heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87(6 Suppl):VI88-VI93.
85. Hart DJ, Spector TD. The classification and assessment of osteoarthritis. Baillieres Clin Rheumatol. 1995;9:407-432.
86. Dannefer D. What's in a name? An account of the neglect of variability in the study of aging. In: Birren JE, Bengston VL, eds. Emergent Theories of Aging. New York: Springer Publishing Company; 1988:356-384.
87. Maddox GL. Aging differently. Gerontologist. 1987;27:557-564.
88. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-1428.
89. Ferrucci L, Baldasseroni S, Bandinelli S, et al. Disease severity and health-related quality of life across different chronic conditions. J Am Geriatr Soc. 2000;48:1490-1495.
90. Kuller LH, Shemanski L, Psaty BM, et al. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation. 1995;92:720-726.
91. Karlamangla A, Tinetti M, Guralnik J, Studenski S, Wetle T, Reuben D. Comorbidity in older adults: nosology of impairments, diseases and conditions. J Gerontol A Biol Sci Med Sci. 2007;62A:296-300.